Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bold

Showing results (41-50 of 183) with videos related to

Pageof 19
Sort By:
The Journal of Surgical Research|May 11, 2010
Targeting Bcl-2-mediated cell death as a novel therapy in pancreatic cancerDiego J Muilenburg, Jodi M Coates, Subbulakshmi Virudachalam, et al.
The Journal of Surgical Research|August 29, 2003
Schedule-dependent molecular effects of the proteasome inhibitor bortezomib and gemcitabine in pancreatic cancerBridget N Fahy, Michael G Schlieman, Subbulakshi Virudachalam, et al.
Cancer Investigation|January 1, 1995
Role of calcium in the regulation of ornithine decarboxylase enzyme activity in mouse colon cancer cellsJ Ishizuka, R J Bold, C M Townsend, et al.
Biochemical and Biophysical Research Communications|August 15, 1994
Gastrin stimulates growth of human colon cancer cells via a receptor other than CCK-A or CCK-BR J Bold, J Ishizuka, C M Townsend, et al.
Archives of Surgery (Chicago, Ill. : 1960)|November 1, 1993
Biomolecular advances in gastrointestinal hormonesR J Bold, J Ishizuka, C M Townsend, et al.
Journal of the American College of Surgeons|March 31, 2004
Inhibition of AKT abrogates chemotherapy-induced NF-kappaB survival mechanisms: implications for therapy in pancreatic cancerBridget N Fahy, Michael G Schlieman, Subbulakshmi Virudachalam, et al.
Frontiers in Psychology|December 29, 2011
A possible physiological basis for the discontinuity of consciousnessSusan Pockett, Barry J Brennan, Gary E J Bold, et al.
Plos One|October 26, 2016
Increased Rates of Prolonged Length of Stay, Readmissions, and Discharge to Care Facilities among Postoperative Patients with Disseminated Malignancy: Implications for Clinical PracticeSarah B Bateni, Frederick J Meyers, Richard J Bold, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 17, 2002
Peritoneal and serum tumor markers predict recurrence and survival of patients with resectable gastric cancerRichard J. Bold, David M. Ota, Jaffer A. Ajani, et al.
Journal of the American College of Surgeons|March 26, 2021
Is Improved Survival in Early-Stage Pancreatic Cancer Worth the Extra Cost at High-Volume Centers?Lauren M Perry, Sarah B Bateni, Richard J Bold, et al.
Pageof 19

Showing results (41-50 of 183) with videos related to

Sort By:
Pageof 19
The Journal of Surgical Research|May 11, 2010
Targeting Bcl-2-mediated cell death as a novel therapy in pancreatic cancerDiego J Muilenburg, Jodi M Coates, Subbulakshmi Virudachalam, et al.
The Journal of Surgical Research|August 29, 2003
Schedule-dependent molecular effects of the proteasome inhibitor bortezomib and gemcitabine in pancreatic cancerBridget N Fahy, Michael G Schlieman, Subbulakshi Virudachalam, et al.
Cancer Investigation|January 1, 1995
Role of calcium in the regulation of ornithine decarboxylase enzyme activity in mouse colon cancer cellsJ Ishizuka, R J Bold, C M Townsend, et al.
Biochemical and Biophysical Research Communications|August 15, 1994
Gastrin stimulates growth of human colon cancer cells via a receptor other than CCK-A or CCK-BR J Bold, J Ishizuka, C M Townsend, et al.
Archives of Surgery (Chicago, Ill. : 1960)|November 1, 1993
Biomolecular advances in gastrointestinal hormonesR J Bold, J Ishizuka, C M Townsend, et al.
Journal of the American College of Surgeons|March 31, 2004
Inhibition of AKT abrogates chemotherapy-induced NF-kappaB survival mechanisms: implications for therapy in pancreatic cancerBridget N Fahy, Michael G Schlieman, Subbulakshmi Virudachalam, et al.
Frontiers in Psychology|December 29, 2011
A possible physiological basis for the discontinuity of consciousnessSusan Pockett, Barry J Brennan, Gary E J Bold, et al.
Plos One|October 26, 2016
Increased Rates of Prolonged Length of Stay, Readmissions, and Discharge to Care Facilities among Postoperative Patients with Disseminated Malignancy: Implications for Clinical PracticeSarah B Bateni, Frederick J Meyers, Richard J Bold, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 17, 2002
Peritoneal and serum tumor markers predict recurrence and survival of patients with resectable gastric cancerRichard J. Bold, David M. Ota, Jaffer A. Ajani, et al.
Journal of the American College of Surgeons|March 26, 2021
Is Improved Survival in Early-Stage Pancreatic Cancer Worth the Extra Cost at High-Volume Centers?Lauren M Perry, Sarah B Bateni, Richard J Bold, et al.
Pageof 19